NEXSPHERE

manufacturer: NEXTBIOMEDICAL CO., LTD.


Category: Treatment of endovascular embolization


  • Resorbable microspheres: Temporary embolization microspheres composed of gelatin
  • Optimal performance: High elasticity and strong cohesion
  • Patented vial design: Vial designed for contamination prevention
  • Tailored to various indications: Resorbable within 24 hours, applicable to various (Nexsphere-H)

 

Description

Indication

Features:

Resorbable microspheres
Temporary embolization microspheres composed of gelatin
Optimal performance
High elasticity and strong cohesion
Patented vial design
Vial designed for contamination prevention
(Korean design patent No : 3009879200000)

 

Preclinical study

Instructions for use

Specifications